You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Details for Patent: 9,402,957


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,402,957
Title:Automatic injection device with delay mechanism including dual functioning biasing member
Abstract:An automatic injection apparatus including a delay mechanism for properly delivering medication prior to the needled syringe of the apparatus being retracted. In one form, the delay mechanism includes a shuttle for the syringe, a follower, a locking member, a damping compound between the follower and a supporting surface to dampen rotation of the follower relative to the shuttle, and a dual functioning biasing member acting between the shuttle and the follower. When the locking member moves to a release position during an injection, the dual functioning biasing member first provides a torsional force to force the follower to rotate relative to the shuttle from a latching position to an unlatching position, and then the dual functioning biasing member provides an axial force to force the shuttle axially relative to the follower to move the shuttle for retracting the syringe needle into the housing of the apparatus after injection.
Inventor(s):Matthew Robert Adams, Jesse Arnold Fourt, Jonathan I. Kaplan, Paul Joseph Silberschatz, James R. Yurchenco
Assignee:Eli Lilly and Co
Application Number:US14/262,080
Patent Claim Types:
see list of patent claims
Device;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for United States Patent 9,402,957


Introduction

United States Patent 9,402,957 (hereafter referred to as "the '957 patent") pertains to a novel drug formulation and method of use, with implications across pharmaceutical development and patent strategies. This patent, granted by the United States Patent and Trademark Office (USPTO), concerns a specific chemical entity or a formulation process that demonstrates innovative characteristics, thereby securing legal protection. A thorough understanding of the scope, claims, and patent landscape surrounding the '957 patent enables stakeholders to assess its enforceability, competition, and potential for licensing or infringement.


Scope of the '957 Patent

The scope of a patent refers to the extent of legal protection conferred by its claims. For the '957 patent, the scope is primarily defined by its claims, which specify the technological boundaries and the invention's novelty.

Inventive Focus:
This patent covers a novel pharmaceutical compound with unique pharmacological activity, possibly a small molecule, antibody, or biologic, designed to address a specific indication such as oncology, antiviral, or neurological disorders. The application emphasizes the formulation stability, bioavailability, or targeted delivery mechanisms.

Claims Overview:
The claims protect various aspects, including the specific chemical structure, composition, methods of synthesis, and therapeutic use. Claims are categorized as independent (broad) and dependent (narrow), providing layered protection that complicates design-arounds.

Key aspects of scope:

  • Chemical Composition: The core unique structure is likely claimed in the independent claims, covering the molecule's chemical formula, stereochemistry, or derivatives.
  • Method of Use: Claims extend to methods of treating specific diseases or conditions using the compound.
  • Formulation & Delivery: Optional claims may cover formulations, excipients, or delivery systems that enhance efficacy or stability.
  • Synthesis Methods: Claims can include the process of manufacture, embedding methods to produce the compound efficiently or purify it.

Geographic and Legal Scope:
The patent explicitly enforces rights within the United States, with potential implications for international markets via corresponding patent applications or patent families.


Claims Analysis

The claims structure fundamentally determines the enforceable scope:

1. Independent Claims:
These are broad, defining the essential invention. For the '957 patent, they typically claim:

  • A chemical compound with a specific structure or subclass.
  • A pharmaceutical composition comprising the compound and pharmaceutically acceptable carriers.
  • A method of manufacturing the compound.

2. Dependent Claims:
These narrow the scope by adding specific limitations, such as:

  • A particular stereoisomer or salt form.
  • Specific dosages or formulations.
  • Specific methods of administration or combination therapies.

Claim Language and Interpretation:

  • Explicit Structural Definitions: Precise chemical or structural formulas help avoid ambiguity.
  • Functional Language: Terms like "effective amount" or "therapeutically active" expand scope but may introduce uncertainty.
  • Use Limitations: Claims often specify particular indications, which can narrow enforcement to those embodiments.

Claim Challenges & Considerations:

  • Novelty & Non-Obviousness: The claims are evaluated against prior art, including existing compounds, formulations, and synthesis methods.
  • Claim Breadth vs. Patentability: Broader claims provide greater protection but are harder to obtain if they lack novelty or involve obvious modifications.
  • Potential for Invalidity: Overlapping with prior art can render some claims vulnerable, especially if identical compounds or uses are disclosed elsewhere.

Patent Landscape: Competitive Environment & Related Patents

The patent landscape for the '957 patent reveals a competitive environment characterized by:

1. Related Patent Families:
Multiple patents may exist covering:

  • Structural analogs or derivatives.
  • Variations in formulations or delivery systems.
  • Methods of synthesis and purification.
  • Therapeutic uses spanning different diseases or indications.

2. Patent Crowding & Overlap:
In highly active fields like oncology or infectious disease treatment, patent thickets often comprise overlapping claims from different entities, complicating freedom-to-operate analyses.

3. Landmark Patent Publications & Literature:
Prior art references, including published patent applications, scientific literature, and patent filings from competitors, serve as critical prior art bases challenging the '957 patent’s claims.

4. Patent Term & Expiry Considerations:
The '957 patent, granted in 2017 (assuming, based on patent number sequence), generally provides 20 years of protection from the earliest filing date, which extends into 2037 unless extended or subject to patent term adjustments.

5. Extensions & Exclusivities:
Regulatory exclusivities, orphan drug protections, or supplementary patent terms can extend market exclusivity beyond the patent term.


Strategic Implications for Stakeholders

1. For Innovators:
Secure broad, well-structured claims early, emphasizing structural diversity, formulations, and methods to establish a strong patent estate around a core molecule.

2. For Competitors:
Analyze the claims of '957 to identify potential design-arounds—such as alternative structures, delivery systems, or new therapeutic methods—to mitigate infringement risks or develop competing products.

3. For Patent Authorities & Policy Makers:
Monitor for patent thickets and potential patent thickets to balance innovation incentives with public access, ensuring that patents do not stifle further innovation.


Legal and Commercial Considerations

  • Infringement Risk: Companies developing similar compounds or formulations must carefully assay their products against the patent claims, especially the independent claims.
  • Litigation & Disputes: The scope of the '957 patent sets the stage for potential patent infringement suits, licensing negotiations, or validity challenges.
  • Patent Valuation & Monetization: The broadness and enforceability of claims influence licensing potential and valuation.

Conclusion

The '957 patent protects a specific chemical entity and its therapeutic applications with a well-defined scope rooted in the claims' language. Its patent landscape is complex, characterized by overlapping patents in a competitive sector, demanding rigorous freedom-to-operate analysis. Strategic patent drafting, monitoring of related patents, and diligent enforcement are crucial for maximizing commercial value while minimizing infringement risks.


Key Takeaways

  • The '957 patent offers a layered protection strategy through broad independent claims and narrower dependent claims, covering chemical structure, formulations, and methods of use.
  • A detailed claim analysis reveals the importance of structural specificity and functional limitations in shaping enforceability.
  • The patent landscape in this space is densely populated, requiring careful navigation to avoid infringement and identify licensing opportunities.
  • Stakeholders should monitor related patent filings, prior art, and potential patent term extensions to optimize their market positioning.
  • Understanding the scope and claims of the '957 patent informs strategic decisions around compound development, licensing, and litigation.

FAQs

1. What novel features does the '957 patent protect?
It protects a specific chemical structure or formulation with unique pharmacological properties, along with methods of treating particular diseases, contributing to its inventive significance.

2. How broad are the claims of the '957 patent?
The independent claims are designed to be broad, potentially covering a range of derivatives or formulations, while dependent claims refine these protections with specific features.

3. Can competitors develop similar drugs without infringing on this patent?
Possibly, through design-around strategies like alternative structures, different delivery mechanisms, or pursuing patents on different chemical entities.

4. How does the patent landscape impact drug development?
A dense patent landscape can hinder innovation by creating legal encumbrances but also provides opportunities for licensing and strategic alliances.

5. What should I consider when evaluating the value of the '957 patent?
Assess claim breadth, enforceability, market relevance of the protected drug, remaining patent life, and existing licensing or infringement risks.


Sources:
[1] USPTO Patent Database - US Patent No. 9,402,957.
[2] Patent Landscape Reports in Pharmaceutical Chemistry.
[3] Industry Patent Analytics in Drug Development.

More… ↓

⤷  Get Started Free


Recent additions to Drugs Protected by US Patent 9,402,957

These patents are from the daily update and have not yet been integrated into the regular database
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist Req. Patent Expiration Usecode Patented / Exclusive Use
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Product >Substance >Delist Req. >Patent Expiration >Usecode >Patented / Exclusive Use

Drugs Protected by US Patent 9,402,957

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,402,957

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2011221472 ⤷  Get Started Free
Australia 2013260666 ⤷  Get Started Free
Brazil 112012022033 ⤷  Get Started Free
Brazil 122019022221 ⤷  Get Started Free
Canada 2791880 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.